Law360, New York (September 01, 2011, 2:26 PM ET) -- A federal judge on Wednesday tossed a putative class action in Indiana accusing Chattem Inc. of deceptively marketing the weight loss pill Dexatrim as safe even though it contains a dangerous carcinogen, finding that consumers failed to demonstrate standing.
The suit relies on a 2010 report that found hexavalent chromium in Dexatrim. U.S. District Judge Sarah Evans Barker said that while that report has alarmed plaintiffs and others, fear over a potential medical consequence in the future isn't enough to show an injury in fact, a...
Dexatrim Maker Wins Dismissal Of Marketing Class Action
To view the full article, take a free trial now.
